A Double-Blind, Placebo-Controlled, Multicenter Study of Cerebrolysin for Alzheimer's Disease-Reference-Cited by-同舟云学术

A Double-Blind, Placebo-Controlled, Multicenter Study of Cerebrolysin for Alzheimer's Disease

Published:2000-12 Issue:12 Volume:48 Page:1566-1571
ISSN:0002-8614
Container-title:Journal of the American Geriatrics Society
language:en
Short-container-title:

Author:

Bae Chul-Young,Cho Choo-Yon,Cho Kyunghee,Oh Byoung Hoon,Choi Kyoung Gyu,Lee Hong Soo,Jung Seung Pil,Kim Dae Hyun,Lee Sangdo,Choi Gyu-Dong,Cho Hangsuk,Lee Hotaek

Publisher

Wiley

Subject

Geriatrics and Gerontology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1532-5415.2000.tb03865.x/fullpdf

Reference33 articles.

1. A 30-week randomized controlled trial of high-dose tacrine in patients with Alzheimer's disease;Knapp;JAMA,1994

2. A controlled trial of tacrine in Alzheimer's disease;Farlow;JAMA,1992

3. A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Alzheimer's disease;Rogers;Neurology,1998

4. Long-term efficacy and safety of donepezil in the treatment of Alzheimer's disease: An interim analysis of the results of a US multi-center open label extension study;Rogers;Eur Neuropsychopharmacol,1998

5. Metrifonate treatment of the cognitive deficits of Alzheimer's disease;Cummings;Neurology,1998

Cited by 55 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacological treatments for vascular dementia: a systematic review and Bayesian network meta-analysis;Frontiers in Pharmacology;2024-08-22

2. Standing Strong: A Systematic Review of Multifaceted Fall Prevention in Older Adults;2024-08-06

3. Cerebrolysin Treatment Reduces the Risk of Mild Cognitive Decline to Dementia in 1st-Degree Relatives of Alzheimer’s Patients: A Prospective Comparative Study;Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova;2023

4. Analysis of neuroprotective medication in patients with neurocognitive disorders: The efficacy and tolerability of highly purified animal tissues extracts;Romanian Journal of Military Medicine;2022-11-01

5. Cerebrolysin for stroke, neurodegeneration, and traumatic brain injury: review of the literature and outcomes;Neurological Sciences;2021-01-30